Observations placeholder
Rituxan
Identifier
015702
Type of Spiritual Experience
Number of hallucinations: 26
Background
A description of the experience
Rituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders.
On Dec, 31, 2016 18,539 people reported to have side effects when taking Rituxan.
Among them, 26 people (0.14%) have Hallucination
On Dec, 19, 2016 18,539 people reported to have side effects when taking Rituxan.
Among them, 1,795 people (9.68%) have Death
Time on Rituxan when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 64.15% | 32.08% | 3.77% | 0.00% | 0.00% | 0.00% | 0.00% |